Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Oct 16, 2025 | Non classé

Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with invasive breast cancer, with an additional 59,080 new cases of non-invasive breast cancer.

While these figures are sobering, there is progress. Early detection significantly improves outcomes. In the US, women diagnosed with localised breast cancer have a five-year survival rate at 99%. Today, over four million breast cancer survivors serve as a testament to the life-saving impact of awareness, early diagnosis and effective access to treatment.

However, the situation in many parts of the world is far more challenging

The African continent is experiencing a breast cancer crisis, with the highest mortality rates globally. Between 60 and 70% of women in African countries are diagnosed at advanced stages, when treatment is more difficult and less effective. In sub-Saharan Africa, half of women diagnosed with breast cancer survive for five years. In high-income countries, that figure exceeds 90%.

The reasons are clear. Early detection is hindered by low awareness and limited access to diagnostic and treatment services. Across many African nations, a single oncologist may care for between 500 and 1,000 patients (up to four times the recommended ratio). For many women, the barriers are not only medical but social. Fear, stigma and financial hardship often delay or prevent them from seeking help.

In this time of challenge, African women are stepping forward to lead change

Launched during Breast Cancer Awareness Month in 2024, the Africa Breast Cancer Council brings together a group of influential leaders – healthcare professionals, oncologists, former ministers, economists and First Ladies – united by a single goal: to change the future of breast cancer care in Africa.

The Council works to drive systemic reform. It aims to make breast cancer a national health priority, strengthen collaboration across governments and institutions, and advocate for scalable, sustainable solutions that improve survival rates for women across the continent.

Dr Magda Robalo, Council member and President of the Institute for Global Health and Development, said:

“Most African women with breast cancer are diagnosed too late and, even after a diagnosis, many do not receive the treatment they need. This egregious injustice is utterly preventable.”

Breast cancer is a global issue, but outcomes should not depend on where a woman lives. This Breast Cancer Awareness Month, the message is simple: awareness saves lives, but access and equity keep them alive.

https://www.nationalbreastcancer.org/breast-cancer-facts/

https://africabreastcancercouncil.org/

https://africa.roche.com/stories/africa-breast-cancer-council

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...

Jeanette Young Shares GCLP Quality Insights with the TASK Team

Jeanette Young Shares GCLP Quality Insights with the TASK Team

On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ  in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...